Login / Signup

Addressing High Drug Prices by Reforming Pharmacy Benefit Managers.

Benjamin N Rome
Published in: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2024)
Recently, Congress has focused on reforms to address pharmacy benefit managers' (PBMs) role in high drug prices for patients. Congress must not excessively restrict PBMs' ability to negotiate with manufacturers; alternatively, reforms could be paired with other policies that address the high prices of brand-name drugs.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • public health
  • chronic kidney disease
  • emergency department
  • peritoneal dialysis
  • prognostic factors
  • adverse drug
  • electronic health record